Search Materials

This report summarizes data from the national TB surveillance system for 2004 and describes trends since 1993. Findings indicate that although the 2004 TB rate was the lowest recorded in the United States since national reporting began in 1953, the declines in rates for 2003 (2.3%) and 2004 (3.3%) were the smallest since 1993...

This is an achievement report about the Global Drug Facility (GDF), a key initiative of the STOP TB Partnership, which has had a positive impact on the treatment of millions of TB patients globally since its establishment in 2001. By providing high-quality TB drugs to over 4.4 million people in some of the world's poorest countries, it has helped to save lives and has significantly strengthened global TB control efforts.

This report summarizes the recommendations of the Association of Public Health Laboratories Task Force on Tuberculosis Laboratory Services. The report describes in greater detail the actions and performance measures that were used to guide development and implementation of an integrated system for providing TB laboratory services...

This Briefing Note outlines a strategic advocacy plan, and provides (1) a listing of key global and regional advocacy events, (2) a short list of suggested activities to implement at national and sub-national levels, and (3) a list of information products that the Stop TB Partnership Secretariat will produce for global distribution.

This World TB Day brochure focuses on the central role of TB health care providers in the fight against TB. It raises awareness about the health threat posed by tuberculosis in the Americas.

This World TB Day bookmark focuses on the central role of TB health care providers in the fight against TB. It raises awareness about the health threat posed by tuberculosis in the Americas.

This report provides standardized recommendations for public health officials, veterinarians, animal venue operators, animal exhibitors, visitors to animal venues and exhibits, and others concerned with disease-control and with minimizing risks associated with animals in public settings. The recommendation to wash hands is the single most important prevention step for reducing the risk for disease transmission...

This report is the proceedings of the Tuberculosis Behavioral and Social Science Research Forum held on December 10-11, 2003 in Atlanta, GA. The Forum's goal was to identify and prioritize TB behavioral and social science research needs, so that a research agenda for TB prevention, control, and treatment could be developed...

This report is an outline of the Expert Consultation on TB/HIV Research Priorities in Resource-limited Setting on 14-16 February 2005 in Geneva, Switzerland. Three discussion groups identified research priorities for five major areas: (1) preventive therapy for TB were identified with a distinction between the population and the individual levels; (2) co-trimoxazole prophylaxis including the role of co-trimoxazole in the context of antiretroviral therapy, delivery strategies, and determining the efficacy of and optimal time for initiating co-trimoxazole prophylaxis among people living with HIV/AIDS and TB; (3) antiretroviral therapy for people living with HIV/AIDS who have TB or who develop TB is validating the optimal time for initiating antiretroviral therapy; (4) intensified case-finding focus on ways to put this TB/HIV collaborative activity into operation to improve TB control; and (5) the development of new tools and diagnostic algorithms to improve the diagnosis of smear-negative TB in adults and children.

This publication describes Lights of Hope, a stand-alone National Tuberculosis Communication Strategy for use in Kenya in the fight against tuberculosis (TB). It is based on a study of health-seeking behaviours among Kenyans, strategy design workshops with stakeholders, and meetings with frontline TB workers...